THURSDAY, Sept. 19, 2024 (HealthDay News) — One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users’ odds for Long COVID. Long COVID can present with symptoms including chronic fatigue, brain fog and chest pain and it may last weeks or months after an initial COVIDContinue Reading

THURSDAY, Sept 19, 2024 (HealthDay News) — Exercise, whether moderate- or high-intensity, can help ease Parkinson’s symptoms, including fatigue, new research shows. As study lead author Dr. Philip Millar explained, Parkinson’s patients are too often overwhelmed by shame or depression, so they stop going to the gym or exercising. That’sContinue Reading

THURSDAY, Sept. 19, 2024 (HealthDay News) — A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream andContinue Reading

WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Cadmium, uranium, cobalt: These and other metals found in the environment can collect in the body and exacerbate heart disease, new research suggests. “Our findings highlight the importance of considering metal exposure as a significant risk factor for atherosclerosis and cardiovascular disease,” saidContinue Reading

WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration’s expanded approval of the treatment, drug maker Novartis announced Tuesday. “The FDA approval of Kisqali for this early breastContinue Reading